
Craig D. Ricci
Examiner (ID: 10445, Phone: (571)270-5864 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1611, 1628, 1614 |
| Total Applications | 1547 |
| Issued Applications | 760 |
| Pending Applications | 153 |
| Abandoned Applications | 681 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20187003
[patent_doc_number] => 12398108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Compounds, compositions, and methods for treating diseases
[patent_app_type] => utility
[patent_app_number] => 18/120757
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6355
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120757
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120757 | Compounds, compositions, and methods for treating diseases | Mar 12, 2023 | Issued |
Array
(
[id] => 19884111
[patent_doc_number] => 12269803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Kruppel-like factor 15 (KLF15) small molecule agonists in kidney disease
[patent_app_type] => utility
[patent_app_number] => 18/116593
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 53
[patent_no_of_words] => 45640
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18116593
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/116593 | Kruppel-like factor 15 (KLF15) small molecule agonists in kidney disease | Mar 1, 2023 | Issued |
Array
(
[id] => 18552099
[patent_doc_number] => 20230250105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
[patent_app_type] => utility
[patent_app_number] => 18/175030
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175030 | Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity | Feb 26, 2023 | Abandoned |
Array
(
[id] => 19638048
[patent_doc_number] => 12168648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-17
[patent_title] => Opioid receptor modulators
[patent_app_type] => utility
[patent_app_number] => 18/168155
[patent_app_country] => US
[patent_app_date] => 2023-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43040
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18168155
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/168155 | Opioid receptor modulators | Feb 12, 2023 | Issued |
Array
(
[id] => 18893856
[patent_doc_number] => 20240009341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => DRESSING, A KIT COMPRISING A DRESSING AND A METHOD OF PREPARING A DRESSING
[patent_app_type] => utility
[patent_app_number] => 18/108443
[patent_app_country] => US
[patent_app_date] => 2023-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18108443
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/108443 | DRESSING, A KIT COMPRISING A DRESSING AND A METHOD OF PREPARING A DRESSING | Feb 9, 2023 | Pending |
Array
(
[id] => 20200394
[patent_doc_number] => 12403159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Therapeutic metal complexes and ligands and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 18/102474
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 12724
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102474
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102474 | Therapeutic metal complexes and ligands and methods of making and using the same | Jan 26, 2023 | Issued |
Array
(
[id] => 18391347
[patent_doc_number] => 20230159565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Solid Forms of Substituted Benzoxaborole and Compositions Thereof
[patent_app_type] => utility
[patent_app_number] => 18/094502
[patent_app_country] => US
[patent_app_date] => 2023-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094502
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/094502 | Solid forms of substituted benzoxaborole and compositions thereof | Jan 8, 2023 | Issued |
Array
(
[id] => 18559757
[patent_doc_number] => 11724991
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-08-15
[patent_title] => Selective 5-LO inhibitors for the treatment of bronchial asthma
[patent_app_type] => utility
[patent_app_number] => 18/094113
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7174
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094113
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/094113 | Selective 5-LO inhibitors for the treatment of bronchial asthma | Jan 5, 2023 | Issued |
Array
(
[id] => 18334709
[patent_doc_number] => 20230126657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => Compositions and Methods for Identifying and Treating Dystonia Disorders
[patent_app_type] => utility
[patent_app_number] => 18/082570
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082570
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082570 | Compositions and Methods for Identifying and Treating Dystonia Disorders | Dec 14, 2022 | Abandoned |
Array
(
[id] => 18725758
[patent_doc_number] => 20230339967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => SOLID FORMS OF AN S1P-RECEPTOR MODULATOR
[patent_app_type] => utility
[patent_app_number] => 17/992457
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992457
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992457 | SOLID FORMS OF AN S1P-RECEPTOR MODULATOR | Nov 21, 2022 | Abandoned |
Array
(
[id] => 19722791
[patent_doc_number] => 20250025542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE
[patent_app_type] => utility
[patent_app_number] => 18/708916
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27553
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -195
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18708916
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/708916 | COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE | Nov 8, 2022 | Pending |
Array
(
[id] => 20328446
[patent_doc_number] => 12458703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Responsive elastic polymers and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 17/982454
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 26
[patent_no_of_words] => 2702
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17982454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/982454 | Responsive elastic polymers and methods of making and using same | Nov 6, 2022 | Issued |
Array
(
[id] => 19667447
[patent_doc_number] => 12180174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => A2-73 crystalline polymorph compositions of matter and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/978818
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 44
[patent_no_of_words] => 23692
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17978818
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/978818 | A2-73 crystalline polymorph compositions of matter and methods of use thereof | Oct 31, 2022 | Issued |
Array
(
[id] => 18496015
[patent_doc_number] => 20230218542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => MEDICAMENT FOR TREATING HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 17/970577
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970577 | MEDICAMENT FOR TREATING HYPERTENSION | Oct 20, 2022 | Abandoned |
Array
(
[id] => 18176952
[patent_doc_number] => 20230037681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => FOOD INGREDIENTS FROM STEVIA REBAUDIANA
[patent_app_type] => utility
[patent_app_number] => 17/969235
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969235 | FOOD INGREDIENTS FROM STEVIA REBAUDIANA | Oct 18, 2022 | Abandoned |
Array
(
[id] => 18149627
[patent_doc_number] => 20230023484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => DEPOT ADMINISTRATION OF ILOPERIDONE
[patent_app_type] => utility
[patent_app_number] => 17/935911
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/935911 | DEPOT ADMINISTRATION OF ILOPERIDONE | Sep 26, 2022 | Abandoned |
Array
(
[id] => 20466613
[patent_doc_number] => 12522646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-13
[patent_title] => Activin receptor type II chimeras and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/945299
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 51459
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17945299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/945299 | Activin receptor type II chimeras and methods of use thereof | Sep 14, 2022 | Issued |
Array
(
[id] => 18141720
[patent_doc_number] => 20230015563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => NUTRITIONAL COMPOSITIONS AND INFANT FORMULA FOR PROMOTING DE NOVO MYEALINATION
[patent_app_type] => utility
[patent_app_number] => 17/943652
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943652 | NUTRITIONAL COMPOSITIONS AND INFANT FORMULA FOR PROMOTING DE NOVO MYEALINATION | Sep 12, 2022 | Pending |
Array
(
[id] => 20371265
[patent_doc_number] => 12478680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Hydrogels with biodegradable crosslinking
[patent_app_type] => utility
[patent_app_number] => 17/930381
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 11353
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 623
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930381 | Hydrogels with biodegradable crosslinking | Sep 6, 2022 | Issued |
Array
(
[id] => 18285418
[patent_doc_number] => 20230100890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => USE OF COMBINED INHALANT CANNABINOID THERAPY IN THE TREATMENT OF MIGRAINE
[patent_app_type] => utility
[patent_app_number] => 17/930218
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930218
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930218 | USE OF COMBINED INHALANT CANNABINOID THERAPY IN THE TREATMENT OF MIGRAINE | Sep 6, 2022 | Abandoned |